Topical Review: A Biopsychosocial Framework for Pediatric Narcolepsy and Idiopathic Hypersomnia
Danielle M Graef1,2, Kelly C Byars1,2, Narong Simakajornboon1,2
1Sleep Center, Divisions of Pulmonary Medicine and Behavioral Medicine/Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Insights
Pediatric central disorders of hypersomnolence (CDH) significantly impair youth functioning. An integrated biopsychosocial model is proposed for better clinical management and research.
Area of Science:
- Pediatric Sleep Medicine
- Neurology
- Psychology
Background:
- Central disorders of hypersomnolence (CDH) in youth present unique challenges.
- Current research is limited, primarily focusing on adult narcolepsy and pediatric narcolepsy type 1.
- Understanding the evolution of morbidity in pediatric CDH requires further investigation.
Purpose of the Study:
- To review current research findings in pediatric central disorders of hypersomnolence (CDH).
- To propose an integrative biopsychosocial model for the clinical management of pediatric CDH.
- To highlight the importance of interdisciplinary care and identify future research directions.
Main Methods:
- A comprehensive literature review was conducted.
- The review synthesized findings from pediatric and adult narcolepsy research.
- Pediatric sleep and chronic pain research were also incorporated to inform the model.
Main Results:
- Youth with CDH experience significant impairments in academic, emotional, and behavioral functioning, as well as reduced quality of life (QOL).
- A complex interplay exists between neurobiological factors, treatment, psychological aspects, sleep, and developmental context.
- Existing research is insufficient to fully understand the mechanisms and progression of morbidity in pediatric CDH.
Conclusions:
- Pharmacotherapy is a first-line treatment for pediatric CDH.
- Routine screening for bio-behavioral and psychosocial functioning, along with QOL, is crucial.
- Early identification of risks for compromised functioning can guide adjunctive interventions by behavioral health specialists.
Objective:
Provide an overview of current research findings in pediatric central disorders of hypersomnolence (CDH) and propose a biopsychosocial model for clinical management, with a focus on interdisciplinary care and future directions for research and clinical practice.
Methods:
Literature review drawing from pediatric and adult narcolepsy, as well as pediatric sleep and chronic pain research to develop an integrative biopsychosocial model for pediatric CDH.
Results:
Youth with CDH are vulnerable to impairments in academics, emotional, and behavioral functioning, activity engagement and quality of life (QOL). There is a complex interrelationship between neurobiological features of disease, treatment-related factors, and psychological, sleep-related, and contextual factors across development. Research is limited largely to adults and pediatric narcolepsy type 1 and the mechanisms and evolution of morbidity remain poorly understood.
Conclusions:
In addition to first-line treatment (pharmacotherapy), routine screening of bio-behavioral and psychosocial functioning and QOL is needed to identify risk for compromised functioning warranting adjunctive interventions with behavioral health specialists.
